Highlights and Quick Summary
- Debt/Equity for the quarter ending March 31, 2023 was 0.13 (a 73.49% increase compared to previous quarter)
- Year-over-year quarterly Debt/Equity decreased by -53.02%
- Annual Debt/Equity for 2022 was 0.19 (a -31.06% decrease from previous year)
- Annual Debt/Equity for 2022 was 0.28 (a Infinity% increase from previous year)
- Annual Debt/Equity for 2021 was 0.0 (a -100.0% decrease from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.
Historical Debt/Equity of Benitec Biopharma LimitedMost recent Debt/Equityof BNTC including historical data for past 10 years.
Interactive Chart of Debt/Equity of Benitec Biopharma Limited
Benitec Biopharma Limited Debt/Equity for the past 10 Years (both Annual and Quarterly)
Business Profile of Benitec Biopharma Limited